{"filing":{"accession_number":"0001654954-26-007800","cik":"0001131399","ticker":"GLAXF","company_name":"GSK plc","form":"6-K","filing_date":"2026-08-24","report_date":"2026-08-24","primary_document":"a8443r.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007800/a8443r.htm"},"events":[{"id":29035,"run_id":26568,"accession_number":"0001654954-26-007800","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"GSK announced the first global regulatory approval of Hibsago (bepirovirsen) in Japan for chronic hepatitis B, representing a significant operational and commercial milestone. The approval is for an innovative functional cure treatment with demonstrated clinical efficacy (19% functional cure rate vs. 1% for standard care), supported by Phase III trial data. This is a material product approval event that would affect investor assessment of GSK's pipeline and commercial prospects, though it does not fit the discrete event categories of M\u0026A, earnings, or executive changes.","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-08-24","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":31176,"accession_number":"0001654954-26-007800","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"GSK announced the first global regulatory approval of Hibsago (bepirovirsen) in Japan for chronic hepatitis B, representing a significant operational and commercial milestone. The approval is for an innovative functional cure treatment with demonstrated clinical efficacy (19% functional cure rate vs. 1% for standard care), supported by Phase III trial data. This is a material product approval event that would affect investor assessment of GSK's pipeline and commercial prospects, though it does not fit the discrete event categories of M\u0026A, earnings, or executive changes.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-24T10:57:39.856000+00:00","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-08-24"}]}